New business models are bringing change for traditional organizations and at the same time creating exciting opportunities for new players. Companies have to address market pressure on their top lines while continuing to deliver growth, profitability, and expansion and keeping better, more cost-efficient patient outcomes at the fore. This is all happening in the face of patent expiration, intensifying generic competition and ever-increasing regulatory complexity as well as global macro-economic uncertainty.

In this rapidly changing environment, where boundaries between industries are blurring, delivering dynamic and inspiring leadership for these companies is all the more vital.

At Amrop, our Swiss and global life sciences practice is set up to meet a broad spectrum of requirements across all areas of the sector, including private equity-backed companies and early-stage life science businesses. We use our deep sector experience, research expertise, and extensive networks to help our clients find and develop leaders from across industries and geographies who have the ability to navigate the future.